Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02060747
Other study ID # OPTIPOST
Secondary ID
Status Completed
Phase N/A
First received January 27, 2014
Last updated February 20, 2017
Start date July 1, 2013
Est. completion date December 2016

Study information

Verified date December 2016
Source Groupe Hospitalier Paris Saint Joseph
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Harrington's metaphorical depiction captures the essence of the problem : "Osteoporosis care of fracture patients has been characterized as the Bermuda Triangle made up of orthopaedists, primary care physicians and osteoporosis experts into which the fracture patient disappears".

The most effective way to achieve this goal is through implementation of coordinator-based post fracture models of care. Exemplar models have been refered to as "Fracture Liaison Service" (United-Kingdom [1-3], Europe [4,5] and Australia [6-8]) "Osteoporosis Coordinator Program" (Canada [9,10]) or "Care Manager Programs" (USA [11,12]).

The objective of this trial is to assess efficacy of a new coordinator-based post-fracture program in the Saint-Joseph Hospital in Paris to improve the management of osteoporosis after fracture thanks to an optimal recommendations practice to reduce the incidence of secondary fractures.

Men and women are included aged over 45 years with fragility wrist and hip fractures.

Evaluation criteria are based on the evidence-based assessment (stratify risk, identify secondary causes of osteoporosis, fracture evaluation), the medication adherence, others prescriptions adherence (osteodensitometry), the incidence of secondary fractures and number of falls.

Number of patients : 200 Duration of the study: 3 years Patients' participation duration: 6 months


Recruitment information / eligibility

Status Completed
Enrollment 480
Est. completion date December 2016
Est. primary completion date October 7, 2016
Accepts healthy volunteers No
Gender All
Age group 45 Years to 95 Years
Eligibility Inclusion Criteria:

- Men and women over 45 years

- Fragility wrist and hip fractures

- Volunteer

Exclusion Criteria:

- Public route accident

- Emergency illness associated

- Short life expectancy

- Not volunteer

- Bedridden patient

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Coordinator-based post fracture program


Locations

Country Name City State
France Groupe hospitalier Paris Saint-Joseph Paris

Sponsors (2)

Lead Sponsor Collaborator
Groupe Hospitalier Paris Saint Joseph Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (1)

1. Mc Lellan AR and al. Osteoprosis Int. 2003; 1028-1034 2. Wright SA and al. Rheumatol Int 2005; 489-490 3. Clunie G and al. J Orthop Nurs 2008; 156-162 4. Boudou L and al. Osteoporos Int 2011; 2099-2016 5. Huntjzens KM ana al. Osteoporos Int 2011; 2119-2135 6. Cooper MS and al. Osteoporos Int 2012; 97-107 7. Inderjeeth CA and al. Med J Aus 2010; 149-153 8. Lih A and al. Osteoporos Int 2011; 849-858 9. Bogoch ER and al. J Bone Joint Surg Am 2006; 25-34 10. SAbder B abd al. J Bone Joint Surg Am 2008; 1197-1205 11. Dell R and al. J Bone Joint Surg Am 2008; 188-194 12. Greene D and al. J Am Acad Nurse Pract 2010; 326-329

Outcome

Type Measure Description Time frame Safety issue
Other Number of rehospitalisation for fracture. 6 months
Other Number of falls over 6 months post-inclusion. 6 months
Primary Percentage of patient with a correct management care. This outcome is a composite outcome wich differ with each fracture type. It will be assess 6 months after patient inclusion.
An adequate management care is defined for each fracture as below.
For wrist fracture: medical visit at J15, osteodensitometry, therapeutic decision if necessary (if not, reasons have to be precised in medical sheet).
For hip fracture: osteodensitometry if necessary, therapeutic (chronic care) decision if necessary (if not, reasons have to be precised in medical sheet).
6 months
Secondary Patient adherence to their osteoporosis medication (Morisky composite score) and exploration (osteodensitometry). 6 months